Source: NuGen.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • NuGen’s (NGMD) InsuJet has been approved by Health Canada for needle-free insulin delivery
  • The InsuJet needle-free injection system can be safely used 5,000 times without risk of injury or cross-contamination
  • The device is approved in over 40 countries
  • NuGen is a specialty medical device company
  • NuGen Medical Devices (NGMD) is up by 9.52 per cent trading at $0.115 per share

NuGen’s (NGMD) InsuJet has been approved by Health Canada for needle-free insulin delivery.

The news follows last year’s general use approval from Health Canada.

The InsuJet needle-free injection system can be safely used 5,000 times without risk of injury or cross-contamination. It is approved in over 40 countries across the globe.

According to Diabetes Canada, there are more than 5.7 million people in the country living with diabetes.

“This is another important milestone in paving the way for diabetics in Canada to be able to easily acquire and use our needle-free injection device to deliver pain-free and fear-free insulin,” said Michael Wright, CEO of NuGen.

“This additional Health Canada approval brings more clarity to the intended use of the device and will further support our marketing initiatives to the diabetic community,” he added. “Our goal is to have our technologies accessible not only to the diabetic community, but to give all patients that are currently burdened with injecting themselves with a needle the option of using a needle-free device.”

NuGen is a specialty medical device company developing needle-free technologies and other innovative medical delivery products.

NuGen Medical Devices (NGMD) is up by 9.52 per cent trading at $0.115 per share as of 12:37 pm EST.

More From The Market Herald
Medicenna - President and CEO, Fahar Merchant.

" Medicenna (TSX:MDNA) closes US$20 million public offering

Medicenna Therapeutics Corp. (MDNA) has closed its

" Titan Medical (TSX:TMD) reports Q2 2022 financial results

Titan Medical (TMD) released financial results for the three and six months ended June 30, 2022.

" Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.

" UniDoc (CSE:UDOC) signs agreement to provide telehealth services in Kenya

UniDoc Health (UDOC) has signed a master equipment deployment and services agreement with Claron Health to provide telehealth services in Kenya.